Avid Bioservices Inc. (CDMO)
NASDAQ: CDMO
· Real-Time Price · USD
12.49
0.00 (0.00%)
At close: Feb 04, 2025, 3:59 PM
Avid Bioservices Revenue Breakdown
| Period Ending | Apr 30, 2023 | Apr 30, 2022 | Apr 30, 2021 | Apr 30, 2020 | Apr 30, 2019 |
|---|---|---|---|---|---|
| Manufacturing Revenue Revenue | 125.42M | 99.28M | 83.68M | 52.05M | 43.43M |
| Manufacturing Revenue Revenue Growth | +26.32% | +18.65% | +60.78% | +19.83% | n/a |
| Process Development Revenue Revenue | 23.85M | 20.32M | 12.19M | 7.66M | 10.17M |
| Process Development Revenue Revenue Growth | +17.40% | +66.65% | +59.22% | -24.73% | n/a |
Operating Expense Breakdown
| Period Ending | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 | Jul 31, 2019 | Apr 30, 2019 | Jan 31, 2019 | Oct 31, 2018 | Jul 31, 2018 | Apr 30, 2018 | Jan 31, 2018 | Oct 31, 2017 | Jul 31, 2017 | Apr 30, 2017 | Jan 31, 2017 | Oct 31, 2016 | Jul 31, 2016 | Apr 30, 2016 | Jan 31, 2016 | Oct 31, 2015 | Jul 31, 2015 | Apr 30, 2015 | Jan 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 10.59M | 8.17M | 6.79M | 6.38M | 6.56M | 6.26M | 7.56M | 7.11M | 6.83M | 6.38M | 5.92M | 5.82M | 5.03M | 4.46M | 5.05M | 4.02M | 4.17M | 3.83M | 3.53M | 3M | 3.53M | 4.46M | 3.57M | 3.24M | 2.82M | 3.21M | 4.18M | 4.82M | 3.87M | 4.21M | 4.71M | 4.58M | 4.98M | 5.06M | 4.71M | 4.52M | 4.42M | 4.9M | 5.19M | 4.33M |
| Selling, General, and Administrative Revenue Growth | +29.59% | +20.24% | +6.46% | -2.67% | +4.69% | -17.15% | +6.36% | +4.04% | +7.04% | +7.90% | +1.67% | +15.60% | +12.85% | -11.77% | +25.81% | -3.55% | +8.92% | +8.42% | +17.76% | -15.22% | -20.74% | +24.80% | +10.21% | +15.13% | -12.41% | -23.14% | -13.29% | +24.75% | -8.21% | -10.53% | +2.79% | -8.09% | -1.50% | +7.39% | +4.16% | +2.45% | -9.86% | -5.57% | +19.95% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.37M | n/a | 3.72M | 3.65M | 6.72M | 5.99M | 7.02M | 8.57M | 16.27M | 15.16M | 14.19M | 13.92M | 11.53M | 11.26M |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | -100.00% | +2.11% | -45.73% | +12.16% | -14.71% | -18.05% | -47.32% | +7.32% | +6.81% | +1.95% | +20.70% | +2.40% | n/a |